The two faces of metallothionein in carcinogenesis: photoprotection against UVR-induced cancer and promotion of tumour survival

Metallothionein is a multi-functional protein that protects the host against toxic heavy metals. Under stressful situations it can protect against oxidative damage, contribute to tissue repair, modulate immune responses and limit inflammatory processes. Recently, metallothionein's role in ultraviolet radiation (UVR)-induced injury has been investigated. These studies have shown that when metallothionein is upregulated following exposure to UVR, it can protect against UVR-induced damage and the subsequent development of skin cancer. We propose that this initial protection is achieved through its anti-oxidant role resulting in reduced oxidative stress, reduced apoptosis, reduced NFkappaB activation and enhanced repair of DNA damage. However, once UVR-induced neoplasia has occurred, the cancer cells can hijack metallothionein's protective functions, resulting in increased tumour progression and malignancy. These two discordant sets of attributes are context-dependent, and represent the two faces of metallothionein.

[1]  D. Lawrence,et al.  Extracellular metallothionein effects on lymphocyte activities. , 1990, Molecular immunology.

[2]  C. Tohyama,et al.  Metallothionein deficiency promotes mouse skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene. , 1998, Cancer research.

[3]  C. Tohyama,et al.  Cutaneous metallothionein induction by ultraviolet B irradiation in interleukin-6 null mice. , 2000, The Journal of investigative dermatology.

[4]  X. Montalban,et al.  Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis , 2001, Journal of Neuroimmunology.

[5]  S. Himeno,et al.  Metallothionein is a crucial protective factor against Helicobacter pylori-induced gastric erosive lesions in a mouse model. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[6]  R. Chung,et al.  A role for extracellular metallothioneins in CNS injury and repair , 2004, Neuroscience.

[7]  K. Sugita,et al.  Immunohistochemical Analysis of Metallothionein Expression in Malignant Melanoma in Japanese Patients , 2001, The American Journal of dermatopathology.

[8]  J. Klein,et al.  Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. , 2001, The Journal of pharmacology and experimental therapeutics.

[9]  B. Fowler,et al.  Metallothionein expression in invasive and in situ breast carcinomas. , 2005, Cancer detection and prevention.

[10]  T. Virolle,et al.  NF‐κB/Egr‐1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death , 2005, The EMBO journal.

[11]  V. Berezin,et al.  Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low‐density lipoprotein receptor family , 2007, Journal of neurochemistry.

[12]  J. Hidalgo,et al.  Retracted: Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis , 2003, Journal of neuroscience research.

[13]  H. Zhang,et al.  Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. , 2000, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[14]  Sean Jiang,et al.  Interaction of metallothionein with tumor suppressor p53 protein , 2006, FEBS letters.

[15]  I. Hashimoto,et al.  Possible role of cutaneous metallothionein in protection against photo-oxidative stress--epidermal localization and scavenging activity for superoxide and hydroxyl radicals. , 1992, Photodermatology, photoimmunology & photomedicine.

[16]  G. Stark,et al.  α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences , 1985, Nature.

[17]  V. Berezin,et al.  Peptides modeled after the alpha-domain of metallothionein induce neurite outgrowth and promote survival of cerebellar granule neurons. , 2009, European journal of cell biology.

[18]  S Thameem Dheen,et al.  Metallothionein 2A expression is associated with cell proliferation in breast cancer. , 2002, Carcinogenesis.

[19]  Metallothionein expression and zinc levels in invasive ductal breast carcinoma. , 1999, Oncology reports.

[20]  R. Palmiter,et al.  Molecular biology of metallothionein gene expression. , 1987, Experientia. Supplementum.

[21]  W. Böcker,et al.  Immunohistochemically demonstrated metallothionein expression in malignant melanoma , 1993, Histopathology.

[22]  J. Koropatnick,et al.  Metallothionein Mediates the Level and Activity of Nuclear Factor ΚB in Murine Fibroblasts , 2004, Journal of Pharmacology and Experimental Therapeutics.

[23]  P. Tan,et al.  Metallothionein 1F mRNA Expression Correlates with Histological Grade in Breast Carcinoma , 2001, Breast Cancer Research and Treatment.

[24]  R. Tyrrell,et al.  Ultraviolet a radiation-induced immediate iron release is a key modulator of the activation of NF-kappaB in human skin fibroblasts. , 2004, The Journal of investigative dermatology.

[25]  B. Bay,et al.  Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells. , 2009, Cancer letters.

[26]  A. Ouellette Metallothionein mRNA expression in fetal mouse organs. , 1982, Developmental biology.

[27]  R. Palmiter,et al.  Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. , 1994, Biochemistry.

[28]  Y. Aragane,et al.  UVB Light Induces Nuclear Factor κB (NFκB) Activity Independently from Chromosomal DNA Damage in Cell-Free Cytosolic Extracts , 1994 .

[29]  G. Weinlich,et al.  Metallothionein‐overexpression as a prognostic factor for progression and survival in melanoma. A prospective study on 520 patients , 2003, The British journal of dermatology.

[30]  Jie Liu,et al.  Metallothionein-I/II Double Knockout Mice Are Hypersensitive to Lead-Induced Kidney Carcinogenesis , 2004, Cancer Research.

[31]  J. Youn,et al.  Immunomodulatory activities of extracellular metallothionein. II. Effects on macrophage functions. , 1995, Journal of toxicology and environmental health.

[32]  S. Beissert,et al.  Phenotypic and Functional Characterization of Ultraviolet Radiation-Induced Regulatory T Cells1 , 2008, The Journal of Immunology.

[33]  A. Ponsonby,et al.  UVR, Vitamin D and Three Autoimmune Diseases—Multiple Sclerosis, Type 1 Diabetes, Rheumatoid Arthritis , 2005, Photochemistry and photobiology.

[34]  M. Ichihashi,et al.  A Zn(II)–glycine complex suppresses UVB‐induced melanin production by stimulating metallothionein expression , 2008, International journal of cosmetic science.

[35]  R. Palmiter,et al.  Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Gange,et al.  Protective effects of cadmium chloride against UVB injury in mouse skin and in cultured human cells: a possible role of cadmium-induced metallothionein. , 1991, Photodermatology, photoimmunology & photomedicine.

[37]  T. Sugiura,et al.  B cell stimulating activity of metallothionein in vitro. , 2000, International journal of immunopharmacology.

[38]  H. Chan,et al.  The protective effect of metallothionein against lipid peroxidation caused by retinoic acid in human breast cancer cells. , 1997, The Journal of pharmacology and experimental therapeutics.

[39]  H. Goulding,et al.  Metallothionein expression in human breast cancer. , 1995, British Journal of Cancer.

[40]  A. Naganuma,et al.  Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. , 1993, Cancer research.

[41]  J. Hidalgo,et al.  Metallothionein Treatment Reduces Proinflammatory Cytokines IL-6 and TNF-α and Apoptotic Cell Death during Experimental Autoimmune Encephalomyelitis (EAE) , 2001, Experimental Neurology.

[42]  I. Bremner Nutritional and physiologic significance of metallothionein. , 1991, Methods in enzymology.

[43]  V. Adhami,et al.  Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. , 2003, Neoplasia.

[44]  C. Tohyama,et al.  Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice. , 2003, Carcinogenesis.

[45]  Terence Dwyer,et al.  Regional Variation in Multiple Sclerosis Prevalence in Australia and Its Association with Ambient Ultraviolet Radiation , 2001, Neuroepidemiology.

[46]  Y. Miyachi,et al.  Suppression of melanogenesis by induction of endogenous intracellular metallothionein in human melanocytes , 2004, Experimental dermatology.

[47]  Y. Aragane,et al.  Ultraviolet Radiation-Induced Regulatory T Cells Not Only Inhibit the Induction but Can Suppress the Effector Phase of Contact Hypersensitivity1 , 2004, The Journal of Immunology.

[48]  S. Dunlop,et al.  Redefining the Role of Metallothionein within the Injured Brain , 2008, Journal of Biological Chemistry.

[49]  J. Inoue,et al.  Regulatory role of metallothionein in NF‐κB activation , 1999 .

[50]  S. Garrett,et al.  Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis. , 2001, The American journal of pathology.

[51]  J. Youn,et al.  Metallothionein-induced suppression of cytotoxic T lymphocyte function: an important immunoregulatory control. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[52]  H. Gali-Muhtasib,et al.  Protective effect of vitamin E on ultraviolet B light–induced damage in keratinocytes , 2002, Molecular carcinogenesis.

[53]  M. Lynes,et al.  Augmented humoral immune function in metallothionein-null mice. , 2000, Toxicology and applied pharmacology.

[54]  J. Lee,et al.  The photoprotective effect of 1,25-dihydroxyvitamin D3 on ultraviolet light B-induced damage in keratinocyte and its mechanism of action. , 1997, Journal of dermatological science.

[55]  N. Miura,et al.  Novel Function of Metallothionein in Photoprotection: Metallothionein-Null Mouse Exhibits Reduced Tolerance Against Ultraviolet B Injury in the Skin , 1998 .

[56]  T. Kimura,et al.  Function of Metallothionein in Gene Expression and Signal Transduction: Newly Found Protective Role of Metallothionein , 2008 .

[57]  D. Lamm,et al.  Metallothionein isoform 3 as a potential biomarker for human bladder cancer. , 2000, Environmental health perspectives.

[58]  P. Tan,et al.  Over‐expression of metallothionein predicts chemoresistance in breast cancer , 2009, The Journal of pathology.

[59]  B. Bay,et al.  Up-regulation of metallothionein isoforms in keloid keratinocytes. , 2006, International journal of molecular medicine.

[60]  C. Scaletta,et al.  Evidence that ferritin is UV inducible in human skin: part of a putative defense mechanism. , 1998, The Journal of investigative dermatology.

[61]  R. Tyrrell,et al.  ACTIVATION OF NF‐KB IN HUMAN SKIN FIBROBLASTS BY THE OXIDATIVE STRESS GENERATED BY UVA RADIATION , 1995, Photochemistry and photobiology.

[62]  G. Weinlich,et al.  Metallothionein – overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients , 2006, British Journal of Cancer.

[63]  S. Tseng,et al.  Keratin classes: molecular markers for different types of epithelial differentiation. , 1983, The Journal of investigative dermatology.

[64]  M. Chatterjee,et al.  Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression. , 2007, Life sciences.

[65]  N. Nishimura,et al.  Lack of metallothionein‐I and ‐II exacerbates the immunosuppressive effect of ultraviolet B radiation and cis‐urocanic acid in mice , 2000, Immunology.

[66]  J. Youn,et al.  Interactions of metallothionein with murine lymphocytes: plasma membrane binding and proliferation. , 1996, Toxicology.

[67]  H. Hashimoto,et al.  Immunohistochemical expression of metallothionein in human bladder cancer: correlation with histopathological parameters and patient survival. , 2002, The Journal of urology.

[68]  M. Vašák Advances in metallothionein structure and functions. , 2005, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[69]  T. Yoshida,et al.  Metallothionein synthesis induced by interferon alpha/beta in mice of various zinc status. , 1996, The Tohoku journal of experimental medicine.

[70]  D. Whiteman,et al.  Isoflavonoid photoprotection in mouse and human skin is dependent on metallothionein. , 2006, The Journal of investigative dermatology.

[71]  Manuela Gariboldi,et al.  Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma , 2008, Laboratory Investigation.

[72]  L. Stitt,et al.  Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder. , 2006, Urology.

[73]  S. Garrett,et al.  Post-transcriptional regulation of metallothionein isoform 1 and 2 expression in the human breast and the MCF-10A cell line. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[74]  J. Lazo,et al.  Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice. , 1999, Carcinogenesis.

[75]  H. V. Van Poppel,et al.  Metallothioneins in Human Kidneys and Associated Tumors , 1999, Nephron.

[76]  T. Schwarz Regulatory T Cells Induced by Ultraviolet Radiation , 2005, International Archives of Allergy and Immunology.

[77]  G. Guillemin,et al.  Metallothionein Treatment Attenuates Microglial Activation and Expression of Neurotoxic Quinolinic Acid Following Traumatic Brain Injury , 2009, Neurotoxicity Research.

[78]  K. Zedeler,et al.  Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases. , 1994, Pathology, research and practice.

[79]  H. Hojo,et al.  Tissue specific induction of metallothionein synthesis by tumor necrosis factor-alpha. , 1992, Research communications in chemical pathology and pharmacology.

[80]  S. Dunlop,et al.  Metallothionein induces a regenerative reactive astrocyte phenotype via JAK/STAT and RhoA signalling pathways , 2010, Experimental Neurology.

[81]  Jung Mogg Kim,et al.  Functions of metallothionein generating interleukin-10-producing regulatory CD4+ T cells potentiate suppression of collagen-induced arthritis. , 2007, Journal of microbiology and biotechnology.

[82]  P. Epstein,et al.  Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.

[83]  T. Dwyer,et al.  Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study , 2003, BMJ : British Medical Journal.

[84]  K. Zedeler,et al.  The prognostic significance of immunohistochemically detectable metallothionein in primary breast carcinomas , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[85]  G. Halliday,et al.  Ultraviolet B but Not A Radiation Activates Suppressor B Cells in Draining Lymph Nodes , 2005, Photochemistry and photobiology.

[86]  M. Kanda,et al.  Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis. , 2009, International journal of oncology.

[87]  K. Horgan,et al.  Metallothionein expression in duct carcinoma in situ of the breast. , 1995, Human pathology.

[88]  R. Matkowski,et al.  Elevated metallothionein (MT) expression in invasive ductal breast cancers predicts tamoxifen resistance. , 2005, Histology and histopathology.

[89]  G. Cavaletti,et al.  Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells. , 2004, Journal of biological regulators and homeostatic agents.

[90]  S. Oikawa,et al.  Role of ultraviolet A-induced oxidative DNA damage in apoptosis via loss of mitochondrial membrane potential and caspase-3 activation. , 1998, Biochemical and biophysical research communications.

[91]  C. Tohyama,et al.  Localization of metallothionein in hair follicles of normal skin and the basal cell layer of hyperplastic epidermis: possible association with cell proliferation. , 1991, The Journal of investigative dermatology.

[92]  A. Michalska,et al.  Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[93]  X.-Y. Lu,et al.  Metallothionein‐null mice exhibit reduced tolerance to ultraviolet B injury in vivo , 2004, Clinical and experimental dermatology.

[94]  C. E. Hildebrand,et al.  Human metallothionein genes: structure of the functional locus at 16q13. , 1990, Genomics.

[95]  J. Jester,et al.  A role for NF-κB–dependent gene transactivation in sunburn , 2000 .

[96]  H. Takano,et al.  Role of metallothionein in lung inflammation induced by ozone exposure in mice. , 2008, Free radical biology & medicine.

[97]  J. Alam,et al.  Metallothionein protects retinal pigment epithelial cells against apoptosis and oxidative stress. , 2002, Experimental eye research.

[98]  B. Epe,et al.  Wavelength dependence of oxidative DNA damage induced by UV and visible light. , 1997, Carcinogenesis.

[99]  A. Ponsonby,et al.  Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. , 2003, Environmental health perspectives.

[100]  C. Séguin,et al.  Expression of the gene encoding metallothionein-3 in organs of the reproductive system. , 1998, DNA and cell biology.

[101]  S. De,et al.  High levels of metallothionein messenger RNAs in male germ cells of the adult mouse. , 1991, Molecular endocrinology.

[102]  M. Karin,et al.  Glucocorticoid hormone receptor mediated induction of metallothionein synthesis in HeLa cells , 1980, Journal of cellular physiology.

[103]  G. Halliday,et al.  B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity. , 2005, The Journal of investigative dermatology.

[104]  L. Beazley,et al.  Metallothionein-IIA promotes neurite growth via the megalin receptor , 2007, Experimental Brain Research.

[105]  J. Vickers,et al.  Protective Role of Metallothioneins in the Injured Mammalian Brain , 2004, Reviews in the neurosciences.

[106]  D. Wynford‐Thomas,et al.  IN VIVO PHOTOINDUCTION OF METALLOTHIONEIN IN HUMAN SKIN BY ULTRAVIOLET IRRADIATION , 1996, The Journal of pathology.

[107]  S. Katiyar,et al.  Grape seed proanthocyanidins inhibit UV-radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling in human epidermal keratinocytes. , 2006, Free radical biology & medicine.

[108]  D. Lawrence,et al.  Manipulations of metallothionein gene dose accelerate the response to Listeria monocytogenes. , 2009, Chemico-biological interactions.

[109]  S. Fukushima,et al.  Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N‐butyl‐N‐(4‐hydroxybutyl)‐nitrosamine , 2003, Cancer science.

[110]  S. Dey,et al.  Metallothionein gene expression and metal regulation during preimplantation mouse embryo development (MT mRNA during early development). , 1991, Developmental biology.

[111]  A. Farrag,et al.  Mean Nuclear Area and Metallothionein Expression in Ductal Breast Tumors: Correlation With Estrogen Receptor Status , 2008, Applied immunohistochemistry & molecular morphology : AIMM.

[112]  W. Schaffner,et al.  The transcription factor MTF‐1 is essential for basal and heavy metal‐induced metallothionein gene expression. , 1994, The EMBO journal.

[113]  R. Cousins,et al.  Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[114]  G. Weinlich,et al.  Comparison of metallothionein‐overexpression with sentinel lymph node biopsy as prognostic factors in melanoma , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[115]  G. Murphy,et al.  The molecular determinants of sunburn cell formation , 2001, Experimental dermatology.

[116]  Hyung Gyun Kim,et al.  Metallothionein-III provides neuronal protection through activation of nuclear factor-kappaB via the TrkA/phosphatidylinositol-3 kinase/Akt signaling pathway. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[117]  Paul J Thornalley,et al.  Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. , 1985, Biochimica et biophysica acta.

[118]  V. Berezin,et al.  The role of metallothionein II in neuronal differentiation and survival , 2003, Brain Research.

[119]  D. Whiteman,et al.  Induction of metallothionein in human skin by routine exposure to sunlight: evidence for a systemic response and enhanced induction at certain body sites. , 2003, The Journal of investigative dermatology.

[120]  R. Palmiter,et al.  Regulation, linkage, and sequence of mouse metallothionein I and II genes , 1984, Molecular and cellular biology.

[121]  B. Pitt,et al.  Antioxidant and antiapoptotic function of metallothioneins in HL-60 cells challenged with copper nitrilotriacetate. , 2000, Chemical research in toxicology.

[122]  J. Kumazawa,et al.  Metallothionein expression is correlated with cisplatin resistance in transitional cell carcinoma of the urinary tract. , 1994, The Journal of urology.

[123]  A. Naba,et al.  Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity. , 2009, International journal of oncology.

[124]  A. Abdel-Mageed,et al.  Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. , 1997, Cancer gene therapy.

[125]  K. Squibb,et al.  Induction of metallothionein and heme oxygenase in rats after inhalation of endotoxin. , 1999, Journal of toxicology and environmental health. Part A.

[126]  J. Hidalgo,et al.  Retracted: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis , 2000, Glia.

[127]  R. Palmiter,et al.  Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[128]  Catherine Méplan,et al.  Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells , 2000, Oncogene.

[129]  R. Alcalde,et al.  Zinc accumulation and metallothionein gene expression in the proliferating epidermis during wound healing in mouse skin , 1999, Histochemistry and Cell Biology.

[130]  Z. Ryoo,et al.  Metallothionein suppresses collagen‐induced arthritis via induction of TGF‐β and down‐regulation of proinflammatory mediators , 2002, Clinical and experimental immunology.

[131]  B. Vallee,et al.  Cell cycle regulation of metallothionein in human colonic cancer cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[132]  R. Tyrrell,et al.  UVA radiation-induced oxidative damage to lipids and proteins in vitro and in human skin fibroblasts is dependent on iron and singlet oxygen. , 1995, Free radical biology & medicine.

[133]  H. Degreef,et al.  Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVB , 2004, Archives of Dermatological Research.

[134]  T. Nakajima,et al.  Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. , 1996, Oncology.

[135]  M. Fear,et al.  Exogenous metallothionein‐IIA promotes accelerated healing after a burn wound , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[136]  D. Knecht,et al.  Metallothionein mediates leukocyte chemotaxis , 2005, BMC Immunology.

[137]  Xiuyun Yin,et al.  The Physiological Roles of Extracellular Metallothionein , 2006, Experimental biology and medicine.

[138]  M. Lynes,et al.  In vivo manipulation of endogenous metallothionein with a monoclonal antibody enhances a T-dependent humoral immune response. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[139]  J. Youn,et al.  Immunomodulatory activities of extracellular metallothionein. I. Metallothionein effects on antibody production. , 1993, Toxicology.

[140]  M. Kanekiyo,et al.  Metallothionein modulates lipopolysaccharide-stimulated tumour necrosis factor expression in mouse peritoneal macrophages , 2002 .

[141]  Yongping Cui,et al.  ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis. , 2003, Biochemical and biophysical research communications.

[142]  S. Katiyar,et al.  Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling. , 2007, Free radical biology & medicine.

[143]  R. Palmiter,et al.  MT-III, a brain-specific member of the metallothionein gene family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[144]  J. Hidalgo,et al.  New insight into the molecular pathways of metallothionein‐mediated neuroprotection and regeneration , 2007, Journal of neurochemistry.

[145]  J. Vickers,et al.  Metallothionein-IIA Promotes Initial Neurite Elongation and Postinjury Reactive Neurite Growth and Facilitates Healing after Focal Cortical Brain Injury , 2003, The Journal of Neuroscience.